The Coulter Automated Laboratory System: who needs human beings in the lab?
You may also be interested in...
Tired of fighting each other in court, the two leading robotics companies have decided to render their IP differences moot through a merger.
Progress for two US-based companies in the race to develop a COVID-19 vaccine.
After double-digit growth in formulation sales across geographies in the fourth quarter, Aurobindo expects to continue the momentum this fiscal year. Meanwhile, it might look for partners for its biologics business, which is now transferred to its fully owned subsidiary for $48m.